The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret
- 15 June 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 372 (3) , 897-903
- https://doi.org/10.1042/bj20021530
Abstract
Substitution of Cys-634 in the extracellular domain of the Ret tyrosine kinase receptor causes its dimerization and activation of its transforming potential. To gain further insight into the molecular basis leading to Ret activation we purified a mutant protein consisting of the entire ectodomain of the Ret carrying a Cys-634→Tyr substitution (EC-RetC634Y). The protein is glycosylated, like the native one, and is biologically active. By using an in vitro cell system we show that EC-RetC634Y inhibits the membrane-bound receptor RetC634Y, interfering with its dimerization. Furthermore, we demonstrate that EC-RetC634Y competes with the wild-type Ret receptor for ligand binding. The results presented support the notion of the possible involvment of glial cell line-derived neurotrophic factor (GDNF) with multiple endocrine neoplasia type 2A (MEN2A) tumours, and describe a useful tool for generating molecular mimetics directed towards specific mutations of the ret oncogene.Keywords
This publication has 16 references indexed in Scilit:
- The GDNF/RET signaling pathway and human diseasesCytokine & Growth Factor Reviews, 2001
- The RET receptor: function in development and dysfunction in congenital malformationTrends in Genetics, 2001
- Molecular Modeling of the Extracellular Domain of the RET Receptor Tyrosine Kinase Reveals Multiple Cadherin-like Domains and a Calcium-binding SiteJournal of Biological Chemistry, 2001
- Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesisJournal of Medical Genetics, 2000
- Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERKPublished by Elsevier ,2000
- A generic protein purification method for protein complex characterization and proteome explorationNature Biotechnology, 1999
- A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.Proceedings of the National Academy of Sciences, 1996
- GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNFCell, 1996
- Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2BScience, 1995
- Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's diseaseNature, 1994